Amgen (AMGN)

Add to Watchlists
Create an Alert
114.98 +1.66  +1.46% NASDAQ Apr 15, 5:00PM BATS Real time Currency in USD
View Full Chart
AMGN Price Chart
View All Events

AMGN Events

Date Type Description
May 13 Dividends Amount: 0.61, Declared Date: Mar 05 2014, Pay Date: Jun 06 2014
Apr 22 Misc Q1 2014 Amgen Earnings Conference Call
Apr 22 Earnings Q1 2014 Amgen Earnings Results. Estimate: 1.81.
Feb 11 Dividends Amount: 0.61, Declared Date: Dec 13 2013, Pay Date: Mar 07 2014
Jan 28 Misc Q4 2013 Amgen Earnings Conference Call
Jan 28 Earnings Q4 2013 Amgen Earnings Release. Estimate: 1.64.
Dec 11 Misc Amgen Conference Call on Post Ash Wrap Up
Nov 19 Misc Amgen Investor Meeting, Aha Scientific Sessions 2013
Nov 12 Dividends Amount: 0.47, Declared Date: Oct 17 2013, Pay Date: Dec 06 2013
Oct 22 Misc Q3 2013 Amgen Earnings Conference Call
View All Performance Charts

AMGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Amgen is up 4.93% over the last year vs S&P 500 Total Return up 18.46%, Pfizer up 0.69%, and Merck up 23.20%.

Get Quote for

Pro Report PDF for AMGN

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AMGN Pro Report PDF

Pro Strategies Featuring AMGN

Did Amgen make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

AMGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Amgen Inc. is an international biotechnology company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotech firm. The company employs approximately 17,000 staff members. Its products include Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Sensipar / Mimpara, Nplate, and Prolia. Epogen and Neupogen were the two most successful biopharmaceutical products at the time of their respective releases. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology, and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AMGN 114.98 +1.66 +1.46% 86.81B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.